China Independent Clinical Laboratory Industry Report,2013-2015
  • Sep./2013
  • Hard Copy
  • USD $1,700
  • Pages:57
  • Single User License
    (PDF Unprintable)       
  • USD $1,600
  • Code: ZYM046
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,400
  • Hard Copy + Single User License
  • USD $1,900
      
Restricted by the health care system and the medical inspection level (Chinese firms mainly lag behind foreign counterparts in molecular diagnostics and other special tests), Chinese independent clinical laboratory market only values RMB2.5-3 billion, equivalent to 2%-3% of the total revenue of medical diagnosis, much lower than 30% in developed countries.

However, in the context of Chinese medical reform, the cost control of public hospitals, the increasing number of patients that primary medical institutions are confronted with, the rapid development of private hospitals and other factors will greatly boost China independent clinical laboratory industry which will grow at a rate over 40%.

The report focuses on the operation, advantages and characteristics of 10 major independent clinical laboratory companies in China on the basis of an analysis on the development environment, the market situation, the competition pattern, the impact of upstream and downstream as well as the prospect of China independent clinical laboratory industry.

In China, among about 110 laboratories engaged in independent medical diagnosis, top four ones, namely Kingmed Diagnostics, ADICON, DiAn Diagnostics and DaAn Health, master more than 70% domestic market share together, all with the chain integrated diagnostic service mode.

As a giant in China independent clinical laboratory industry, Kingmed Diagnostics has maintained a revenue growth rate of more than 50% in the past five years. It achieved the revenue of over RMB1 billion in 2012 with 21 laboratories, over 13,000 clients (including more than 1,000 Grade-A hospitals) and 1,600 types of inspection services. Moreover, the company has received two rounds of capital injection from Lenovo, and always stood at the leading position of the industry.

ADICON and DiAn Diagnostics are located in the second echelon in the industry.

ADICON targets at the high-end field (including 220 special inspection items), with 15 laboratories, only second to Kingmed Diagnostics. In June 2012, the subsidiary Hefei ADICON became a designated cervical and breast cancer diagnosis institution in Hefei by virtue of the strong and efficient diagnostic service network.

China's first listed independent clinical laboratory enterprise DiAn Diagnostics gained the revenue of RMB414 million from independent medical diagnostic services in 2012, up 52.2% year on year. DiAn Diagnostics shows significant unique competitive advantages, reflected in hierarchical management and "agency + services" business model. As of the end of 2012, DiAn Diagnostics owned 13 independent diagnostic laboratories, and planned to establish 15 Class-A laboratories and 30 Class-B ones by 2016 for the purpose of the overall improvement in the service response speed.
1 Overview of Independent Medical Diagnosis 
1.1 Definition
1.2 Industry Chain

2 Overview of China Independent Clinical Laboratory Industry 
2.1 Policy 
2.1.1 Access Policy
2.1.2 Industrial Policy
2.2 Impact of International Market 
2.2.1 Market Situation
2.2.2 Key Enterprises
2.3 Status Quo 
2.4 Competition Pattern
2.5 Development Prospect and Trend 

3 Upstream and Downstream of China Independent Clinical Laboratory Industry
3.1 Impact of Upstream Market
3.1.1 Market Situation
3.1.2 Competition Pattern
3.2 Impact of Downstream Development
3.2.1 Huge Independent Medical Diagnosis Market
3.2.2 Health Care Reform Propels the Rapid Development of the Independent Medical Diagnosis Market
3.2.3 Diversified Demand Will Promote the Upgrading of the Independent Clinical Laboratory Industry

4 Major Independent Clinical Laboratory Enterprises in China
4.1 Kingmed Diagnostics
4.1.1 Profile
4.1.2 Status Quo and Prospect 
4.2 Hangzhou ADICON 
4.3 DiAn Diagnostics 
4.3.1 Profile
4.3.2 Operation
4.3.3 Business Structure 
4.3.4 Gross Margin 
4.3.5 Clients and Suppliers 
4.3.6 R & D and Investment 
4.3.7 Independent Medical Diagnostic Services
4.3.8 Development Prospect and Trend 
4.4 Da An Gene
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure 
4.4.4 Gross Margin 
4.4.5 Clients and Suppliers 
4.4.6 R & D
4.4.7 Independent Medical Diagnostic Services
4.5 Beijing NYMPHAVN 
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure 
4.5.4 Gross Margin 
4.5.5 Clients 
4.5.6 R & D and Investment 
4.6 CapitalBio 
4.7 Beijing Adinovo 
4.8 Hangzhou Zhiyuan 
4.9 Kindstar Global (Beijing)
4.10 Deyi Diagnostics

Schematic Diagram of Independent Medical Diagnostic Industry Chain
Comparison between China and the U.S. in Medical Diagnosis Providers
Relevant Policies of China Independent Medical Diagnostic Industry, 2010-2012
Market Share of the U.S. Independent Medical Inspection Industry by Item 
U.S. Medical Inspection Market Share (by Provider)
Revenue and Operating Profit of Quest Diagnostics, 2007-2013
Revenue Structure of Quest Diagnostics (by Business), 2011-2012
Major M & A Events of Quest Diagnostics, 2006-2013
Sales and Operating Profit of Labcorp, 2007-2013 
Revenue of Labcorp (by Business), 2009-2013 
Major M & A Events of Labcorp, 2007-2012
Comparison between Massachusetts General Hospital and One Chinese Grade-A Hospital in Top Five Outbound Inspection Items
Basic Characteristics and Market Share of Major Independent Clinical Laboratory Enterprises in China, by the end of 2012
Market Scale and Growth Rate of In Vitro Diagnostic Industry in China, 2007-2015E
Market Scale and Growth Rate of In Vitro Diagnostic Reagents in China, 2007-2015E
Structure of In Vitro Diagnostic Reagents in China, 2012
Chinese In Vitro Diagnostic Reagent Market Segments, 2012
Business and Inspection Revenue of Medical Institutions in China, 2010
Number of Patients of Hospitals and Primary Health Care Institutions in China, 2008-2012
Number of Public and Private Hospitals in China, 2008-2012
Revenue and YoY Growth Rate of Kingmed Diagnostics, 2008-2012
Distribution and Establishment Time of Independent Medical Laboratories of Hangzhou ADICON
Layout of Independent Diagnostic Laboratories of DiAn Diagnostics, by the end of 2012
Revenue and Profit of DiAn Diagnostics, 2008-2013 
Revenue and Net Income of Top Five Subsidiaries of DiAn Diagnostics, 2011-2012
Revenue of DiAn Diagnostics (by Business), 2008-2013 
Revenue Structure of DiAn Diagnostics (by Business), 2008-2013 
Revenue of DiAn Diagnostics (by Region), 2008-2011
Revenue of DiAn Diagnostics (by Region), 2011-2013
Gross Margin of DiAn Diagnostics (by Business), 2008-2013 
Revenue of DiAn Diagnostics from Top 5 Clients and % of Total Revenue, 2008-2013
Name List and Revenue Contribution of Top 5 Clients of DiAn Diagnostics, 2010-2013
Procurement of DiAn Diagnostics from Top 5 Suppliers and % of Total Procurement, 2008-2012 
Name List and Procurement of Top 5 Suppliers of DiAn Diagnostics, 2009-2011 
R&D Costs and % of Total Revenue of DiAn Diagnostics, 2008-2013
Revenue and Gross Margin of Independent Diagnostic Business of DiAn Diagnostic, 2008-2013
Revenue and Gross Margin of Independent Diagnostic Business of DiAn Diagnostic (by Product), 2008-2012
Revenue Percentage of Independent Diagnostic Business of DiAn Diagnostics (by Client), 2010-2012
Revenue and Operating Income of DiAn Diagnostics, 2012-2015E 
Revenue and Profit of Da An Gene, 2008-2013
Revenue of Da An Gene (by Product), 2008-2012 
Revenue Structure of Da An Gene (by Region), 2008-2012 
Gross Margin of Da An Gene (by Product), 2008-2012 
Name List and Revenue Contribution of Top 5 Clients of Da An Gene, 2012
Name List and Procurement of Top 5 Suppliers of Da An Gene, 2012
R&D Costs and % of Total Revenue of Da An Gene, 2010-2012
Revenue and Gross Margin of Medical Laboratory Services of Da An Gene, 2008-2012
Registered Capital, Revenue and Net Income of Medical Laboratory Subsidiaries of Da An Gene, 2012 
Revenue and Profit of NYMPHAVN, 2009-2013 
Revenue of NYMPHAVN (by Product), 2009-2013 
Revenue of NYMPHAVN (by Region), 2010-2012
Gross Margin of NYMPHAVN (by Product), 2009-2013 
NYMPHAVN’s Revenue from Top 5 Clients and % of Total Revenue, 2009-2013
Name List and Revenue Contribution of NYMPHAVN’s Top 5 Clients, 2012-2013
R&D Costs and % of Total Revenue of NYMPHAVN, 2009-2012 
Some Strategic Copartners of Adinovo
Major Events of Kindstar Global 

China Dental Industry Report, 2014-2018

Oral industry refers to the medical industry chain on the basis of oral medical consumption, mainly covering oral medical apparatus (equipment and consumables) and oral medical services. As reform of ...

China Medical Monitor Industry Report, 2014-2017

With advancement of medical reform, improvement of spending power, and enhancement of health care consciousness, China’s medical monitor industry is gradually expanding. During 2007-2013, the market s...

China Independent Clinical Laboratory Industry Report, 2014-2017

The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there...

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...

China Hospital Development and Investment Report, 2014-2017

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...

China Diagnostic Reagent Industry Report, 2013-2016

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic re...

China Hemodialysis Equipment Import and Export Report, 2013-2016

Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market sho...

Global and China Hemodialysis Industry Report, 2013-2016

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure. In 2013, the global number of patient...

China Portable Medical Equipment Industry Report, 2013-2016

With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with mar...

China Medical Informatization Industry Report,2013-2016

Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, manage...

China Aged Care Industry Report, 2013-2016

Currently, China has entered the accelerated aging period. China’s population aged 65 and above reached 131.61 million in 2013, accounting for 9.7% of total population; and the proportion will rise to...

China Pharmaceutical Equipment Industry Report, 2013-2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total pro...

China Dental Industry Report, 2013-2016

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental appliances (equipments and consumables), dental medical services, etc. with...

China Medical Monitor Industry Report, 2013-2015

In 2007-2011, the Chinese medical monitor market size rose from RMB1.16 billion to RMB3.08 billion at a CAGR of 27.8%. In 2012, the figure reached RMB3.86 billion, a year-on-year increase of 25.3%, of...

China Interventional Cardiovascular Device Industry Report, 2013-2015

With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republi...

China Diagnostic Reagent Industry Report, 2013-2015

Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统